Racial/Ethnic Disparities in Post-acute Sequelae of SARS-CoV-2 Infection in New York: an EHR-Based Cohort Study from the RECOVER Program

Overview

Journal J Gen Intern Med

Publisher Springer

Specialty General Medicine

Date 2023 Feb 16

PMID 36795327

Authors

Dhruv Khullar

Yongkang Zhang

Chengxi Zang

Zhenxing Xu

Fei Wang

Mark G Weiner

Thomas W Carton

Russell L Rothman

Jason P Block

Rainu Kaushal

Affiliations

Soon will be listed here.

Abstract

Background: Compared to white individuals, Black and Hispanic individuals have higher rates of COVID-19 hospitalization and death. Less is known about racial/ethnic differences in post-acute sequelae of SARS-CoV-2 infection (PASC).

Objective: Examine racial/ethnic differences in potential PASC symptoms and conditions among hospitalized and non-hospitalized COVID-19 patients.

Design: Retrospective cohort study using data from electronic health records.

Participants: 62,339 patients with COVID-19 and 247,881 patients without COVID-19 in New York City between March 2020 and October 2021.

Main Measures: New symptoms and conditions 31-180 days after COVID-19 diagnosis.

Key Results: The final study population included 29,331 white patients (47.1%), 12,638 Black patients (20.3%), and 20,370 Hispanic patients (32.7%) diagnosed with COVID-19. After adjusting for confounders, significant racial/ethnic differences in incident symptoms and conditions existed among both hospitalized and non-hospitalized patients. For example, 31-180 days after a positive SARS-CoV-2 test, hospitalized Black patients had higher odds of being diagnosed with diabetes (adjusted odds ratio [OR]: 1.96, 95% confidence interval [CI]: 1.50-2.56, q<0.001) and headaches (OR: 1.52, 95% CI: 1.11-2.08, q=0.02), compared to hospitalized white patients. Hospitalized Hispanic patients had higher odds of headaches (OR: 1.62, 95% CI: 1.21-2.17, q=0.003) and dyspnea (OR: 1.22, 95% CI: 1.05-1.42, q=0.02), compared to hospitalized white patients. Among non-hospitalized patients, Black patients had higher odds of being diagnosed with pulmonary embolism (OR: 1.68, 95% CI: 1.20-2.36, q=0.009) and diabetes (OR: 2.13, 95% CI: 1.75-2.58, q<0.001), but lower odds of encephalopathy (OR: 0.58, 95% CI: 0.45-0.75, q<0.001), compared to white patients. Hispanic patients had higher odds of being diagnosed with headaches (OR: 1.41, 95% CI: 1.24-1.60, q<0.001) and chest pain (OR: 1.50, 95% CI: 1.35-1.67, q < 0.001), but lower odds of encephalopathy (OR: 0.64, 95% CI: 0.51-0.80, q<0.001).

Conclusions: Compared to white patients, patients from racial/ethnic minority groups had significantly different odds of developing potential PASC symptoms and conditions. Future research should examine the reasons for these differences.

Citing Articles

Differences in COVID-19-Related Hospitalization, Treatment, Complications, and Death by Race and Ethnicity and Area-Level Measures Among Individuals with Cancer in the ASCO Registry.

Ashrafi A, Lin Y, Fong A, Islam J, Anderson T, Ganesan S Cancers (Basel). 2025; 17(5).

PMID: 40075704 PMC: 11898501. DOI: 10.3390/cancers17050857.

Minority health social vulnerability index and long COVID illness among a statewide, population-based study of adults with polymerase chain reaction-confirmed SARS-CoV-2.

Ryu S, Allgood K, Xie Y, Orellana R, Fleischer N Arch Public Health. 2025; 83(1):64.

PMID: 40065411 PMC: 11892128. DOI: 10.1186/s13690-025-01553-z.

Episodic disability framework in the context of Long COVID: Findings from a community-engaged international qualitative study.

OBrien K, Brown D, McDuff K, Clair-Sullivan N, Chan Carusone S, Thomson C PLoS One. 2025; 20(2):e0305187.

PMID: 40014600 PMC: 11867324. DOI: 10.1371/journal.pone.0305187.

Living with Long COVID in a Southern State: A Comparison of Black and White Residents of North Carolina.

Pilkington W, Bauer B, Doherty I Int J Environ Res Public Health. 2025; 22(2).

PMID: 40003504 PMC: 11855031. DOI: 10.3390/ijerph22020279.

Ethnic and racial differences in children and young people with respiratory and neurological post-acute sequelae of SARS-CoV-2: an electronic health record-based cohort study from the RECOVER Initiative.

Rao S, Azuero-Dajud R, Lorman V, Landeo-Gutierrez J, Rhee K, Ryu J EClinicalMedicine. 2025; 80:103042.

PMID: 39850015 PMC: 11753962. DOI: 10.1016/j.eclinm.2024.103042.

References

Hawkins D . Differential occupational risk for COVID-19 and other infection exposure according to race and ethnicity. Am J Ind Med. 2020; 63(9):817-820. PMC: 7323065. DOI: 10.1002/ajim.23145. View

Forrest C, McTigue K, Hernandez A, Cohen L, Cruz H, Haynes K . PCORnet® 2020: current state, accomplishments, and future directions. J Clin Epidemiol. 2020; 129:60-67. PMC: 7521354. DOI: 10.1016/j.jclinepi.2020.09.036. View

Chowkwanyun M, Reed Jr A . Racial Health Disparities and Covid-19 - Caution and Context. N Engl J Med. 2020; 383(3):201-203. DOI: 10.1056/NEJMp2012910. View

Colla C, Morden N, Sequist T, Schpero W, Rosenthal M . Choosing wisely: prevalence and correlates of low-value health care services in the United States. J Gen Intern Med. 2014; 30(2):221-8. PMC: 4314495. DOI: 10.1007/s11606-014-3070-z. View

Groff D, Sun A, Ssentongo A, Ba D, Parsons N, Poudel G . Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw Open. 2021; 4(10):e2128568. PMC: 8515212. DOI: 10.1001/jamanetworkopen.2021.28568. View

Xie Y, Xu E, Al-Aly Z . Risks of mental health outcomes in people with covid-19: cohort study. BMJ. 2022; 376:e068993. PMC: 8847881. DOI: 10.1136/bmj-2021-068993. View

Bruce L, Tallman R . Promoting racial equity in COVID-19 resource allocation. J Med Ethics. 2021; . DOI: 10.1136/medethics-2020-106794. View

Wallace J, Jiang K, Goldsmith-Pinkham P, Song Z . Changes in Racial and Ethnic Disparities in Access to Care and Health Among US Adults at Age 65 Years. JAMA Intern Med. 2021; 181(9):1207-1215. PMC: 8314180. DOI: 10.1001/jamainternmed.2021.3922. View

Kriss J, Hung M, Srivastav A, Black C, Lindley M, Lee J . COVID-19 Vaccination Coverage, by Race and Ethnicity - National Immunization Survey Adult COVID Module, United States, December 2020-November 2021. MMWR Morb Mortal Wkly Rep. 2022; 71(23):757-763. PMC: 9181054. DOI: 10.15585/mmwr.mm7123a2. View

10.

Xie Y, Xu E, Bowe B, Al-Aly Z . Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022; 28(3):583-590. PMC: 8938267. DOI: 10.1038/s41591-022-01689-3. View

11.

Bowe B, Xie Y, Xu E, Al-Aly Z . Kidney Outcomes in Long COVID. J Am Soc Nephrol. 2021; 32(11):2851-2862. PMC: 8806085. DOI: 10.1681/ASN.2021060734. View

12.

Cohen K, Ren S, Heath K, Dasmarinas M, Jubilo K, Guo Y . Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022; 376:e068414. PMC: 8828141. DOI: 10.1136/bmj-2021-068414. View

13.

Daugherty S, Guo Y, Heath K, Dasmarinas M, Jubilo K, Samranvedhya J . Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021; 373:n1098. PMC: 8132065. DOI: 10.1136/bmj.n1098. View

14.

Shippee T, Akosionu O, Ng W, Woodhouse M, Duan Y, Thao M . COVID-19 Pandemic: Exacerbating Racial/Ethnic Disparities in Long-Term Services and Supports. J Aging Soc Policy. 2020; 32(4-5):323-333. PMC: 9152947. DOI: 10.1080/08959420.2020.1772004. View

15.

Al-Aly Z, Xie Y, Bowe B . High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021; 594(7862):259-264. DOI: 10.1038/s41586-021-03553-9. View

16.

Su Y, Yuan D, Chen D, Ng R, Wang K, Choi J . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022; 185(5):881-895.e20. PMC: 8786632. DOI: 10.1016/j.cell.2022.01.014. View

17.

Yancy C . COVID-19 and African Americans. JAMA. 2020; 323(19):1891-1892. DOI: 10.1001/jama.2020.6548. View

18.

Lopez 3rd L, Hart 3rd L, Katz M . Racial and Ethnic Health Disparities Related to COVID-19. JAMA. 2021; 325(8):719-720. DOI: 10.1001/jama.2020.26443. View

19.

Yoo S, Liu T, Motwani Y, Sim M, Viswanathan N, Samras N . Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort. J Gen Intern Med. 2022; 37(8):1988-1995. PMC: 8989256. DOI: 10.1007/s11606-022-07523-3. View

20.

Rhew I, Vander Stoep A, Kearney A, Smith N, Dunbar M . Validation of the normalized difference vegetation index as a measure of neighborhood greenness. Ann Epidemiol. 2011; 21(12):946-52. PMC: 3225119. DOI: 10.1016/j.annepidem.2011.09.001. View